Renaissance Technologies’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
Other funds holding VRCA
LT
Renaissance Technologies's VRCA Position: Q3 2026 in Review
Renaissance Technologies increased its Verrica Pharmaceuticals (VRCA) stake by 46% in Q3 2026, buying an estimated $52.8K and bringing the position to 31,884 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #2958.
Renaissance Technologies first reported a position in VRCA in Q4 2019 and has held it in 16 quarters since. The position peaked at $919K in Q2 2023. 26 funds tracked by Wall St. Rank hold VRCA as of Q3 2026.
- Renaissance Technologies held 31,884 shares of Verrica Pharmaceuticals worth $153K as of Q3 2026.
- Renaissance Technologies bought 10,115 Verrica Pharmaceuticals shares in Q3 2026, an estimated $52.8K.
- Verrica Pharmaceuticals made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #2958 holding.
- Renaissance Technologies first reported a position in Verrica Pharmaceuticals in Q4 2019 and has held it in 16 quarters since.
- Renaissance Technologies's Verrica Pharmaceuticals position peaked at $919K in Q2 2023.
- 26 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2026.
Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.